These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32916287)

  • 1. Identification of nonlinear features in cortical and subcortical signals of Parkinson's Disease patients via a novel efficient measure.
    Özkurt TE; Akram H; Zrinzo L; Limousin P; Foltynie T; Oswal A; Litvak V
    Neuroimage; 2020 Dec; 223():117356. PubMed ID: 32916287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
    Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
    Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.
    Hirschmann J; Hartmann CJ; Butz M; Hoogenboom N; Ozkurt TE; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Brain; 2013 Dec; 136(Pt 12):3659-70. PubMed ID: 24154618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
    Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential dopaminergic modulation of spontaneous cortico-subthalamic activity in Parkinson's disease.
    Sharma A; Vidaurre D; Vesper J; Schnitzler A; Florin E
    Elife; 2021 Jun; 10():. PubMed ID: 34085932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease.
    Litvak V; Jha A; Eusebio A; Oostenveld R; Foltynie T; Limousin P; Zrinzo L; Hariz MI; Friston K; Brown P
    Brain; 2011 Feb; 134(Pt 2):359-74. PubMed ID: 21147836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping Subcortico-Cortical Coupling-A Comparison of Thalamic and Subthalamic Oscillations.
    Steina A; Sure S; Butz M; Vesper J; Schnitzler A; Hirschmann J
    Mov Disord; 2024 Apr; 39(4):684-693. PubMed ID: 38380765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.
    Kühn AA; Kupsch A; Schneider GH; Brown P
    Eur J Neurosci; 2006 Apr; 23(7):1956-60. PubMed ID: 16623853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease.
    Özkurt TE; Butz M; Homburger M; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Exp Neurol; 2011 Jun; 229(2):324-31. PubMed ID: 21376039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.
    Androulidakis AG; Kühn AA; Chen CC; Blomstedt P; Kempf F; Kupsch A; Schneider GH; Doyle L; Dowsey-Limousin P; Hariz MI; Brown P
    Brain; 2007 Feb; 130(Pt 2):457-68. PubMed ID: 17213215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized beamforming for simultaneous MEG and intracranial local field potential recordings in deep brain stimulation patients.
    Litvak V; Eusebio A; Jha A; Oostenveld R; Barnes GR; Penny WD; Zrinzo L; Hariz MI; Limousin P; Friston KJ; Brown P
    Neuroimage; 2010 May; 50(4):1578-88. PubMed ID: 20056156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexity of subthalamic 13-35 Hz oscillatory activity directly correlates with clinical impairment in patients with Parkinson's disease.
    Chen CC; Hsu YT; Chan HL; Chiou SM; Tu PH; Lee ST; Tsai CH; Lu CS; Brown P
    Exp Neurol; 2010 Jul; 224(1):234-40. PubMed ID: 20353774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
    Ozturk M; Abosch A; Francis D; Wu J; Jimenez-Shahed J; Ince NF
    Mov Disord; 2020 Jan; 35(1):91-100. PubMed ID: 31348550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.
    Geng X; Zhang J; Jiang Y; Ashkan K; Foltynie T; Limousin P; Zrinzo L; Green A; Aziz T; Brown P; Wang S
    Neurobiol Dis; 2017 Feb; 98():100-107. PubMed ID: 27940307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation modulates synchrony within spatially and spectrally distinct resting state networks in Parkinson's disease.
    Oswal A; Beudel M; Zrinzo L; Limousin P; Hariz M; Foltynie T; Litvak V; Brown P
    Brain; 2016 May; 139(Pt 5):1482-96. PubMed ID: 27017189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.